148 related articles for article (PubMed ID: 20152808)
41. Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.
Gu C; Yokota N; Gao Y; Amano S; Koizumi S; Tokuyama T; Namba H
Neurol Med Chir (Tokyo); 2012; 52(2):62-7. PubMed ID: 22362285
[TBL] [Abstract][Full Text] [Related]
42. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
Frappier L
Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
[TBL] [Abstract][Full Text] [Related]
43. Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product.
Wilkinson GW; Kelly C; Sinclair JH; Rickards C
J Gen Virol; 1998 May; 79 ( Pt 5)():1233-45. PubMed ID: 9603339
[TBL] [Abstract][Full Text] [Related]
44. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).
Ruiz-Jarabo CM; Ly C; Domingo E; de la Torre JC
Virology; 2003 Mar; 308(1):37-47. PubMed ID: 12706088
[TBL] [Abstract][Full Text] [Related]
45. Dual roles for lysine 490 of promyelocytic leukemia protein in the transactivation of glucocorticoid receptor-interacting protein 1.
Liu ST; Lu GY; Hsu YJ; Chang LC; Ho CL; Huang SM
Biochim Biophys Acta; 2013 Aug; 1833(8):1799-810. PubMed ID: 23542129
[TBL] [Abstract][Full Text] [Related]
46. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
Sivachandran N; Sarkari F; Frappier L
PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
[TBL] [Abstract][Full Text] [Related]
48. Myristoylation of the RING finger Z protein is essential for arenavirus budding.
Perez M; Greenwald DL; de la Torre JC
J Virol; 2004 Oct; 78(20):11443-8. PubMed ID: 15452271
[TBL] [Abstract][Full Text] [Related]
49. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid.
Vázquez-Calvo Á; Martín-Acebes MA; Sáiz JC; Ngo N; Sobrino F; de la Torre JC
Antiviral Res; 2013 Aug; 99(2):172-9. PubMed ID: 23735299
[TBL] [Abstract][Full Text] [Related]
51. [Implication of PML nuclear bodies in intrinsic and innate immunity].
Maroui MA; El Asmi F; Dutrieux J; Chelbi-Alix MK; Nisole S
Med Sci (Paris); 2014; 30(8-9):765-71. PubMed ID: 25174753
[TBL] [Abstract][Full Text] [Related]
52. Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene.
Marcos-Villar L; Lopitz-Otsoa F; Gallego P; Muñoz-Fontela C; González-Santamaría J; Campagna M; Shou-Jiang G; Rodriguez MS; Rivas C
J Virol; 2009 Sep; 83(17):8849-58. PubMed ID: 19553342
[TBL] [Abstract][Full Text] [Related]
53. Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.
Zhao LY; Colosimo AL; Liu Y; Wan Y; Liao D
J Virol; 2003 Nov; 77(21):11809-21. PubMed ID: 14557665
[TBL] [Abstract][Full Text] [Related]
54. RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.
Sánchez AB; Perez M; Cornu T; de la Torre JC
J Virol; 2005 Sep; 79(17):11071-81. PubMed ID: 16103158
[TBL] [Abstract][Full Text] [Related]
55. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
56. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
57. Arenavirus extinction through lethal mutagenesis.
de la Torre JC
Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
[TBL] [Abstract][Full Text] [Related]
58. Promyelocytic leukemia protein is a restriction factor for Junín virus independently of Z matrix protein.
Giovannoni F; Vazquez CA; Thomas P; Gómez RM; García CC
Biochem Biophys Res Commun; 2022 May; 606():168-173. PubMed ID: 35364325
[TBL] [Abstract][Full Text] [Related]
59. Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein.
Isakson P; Bjørås M; Bøe SO; Simonsen A
Blood; 2010 Sep; 116(13):2324-31. PubMed ID: 20574048
[TBL] [Abstract][Full Text] [Related]
60. TTRAP is a novel PML nuclear bodies-associated protein.
Xu GL; Pan YK; Wang BY; Huang L; Tian L; Xue JL; Chen JZ; Jia W
Biochem Biophys Res Commun; 2008 Oct; 375(3):395-8. PubMed ID: 18706885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
